# Auriga Partners: portfolio, investments and team > Auriga Partners is a vc firm based in France. 146 investments on record, latest Jul 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/auriga-partners (Millionrounds; every figure on the page links to its filing or article) France · [Investor](https://millionrounds.com/investors) # Auriga Partners Filed with the SEC to raise a fund in Oct 2026, closing $89M. Last cheque observed Jul 2015. Email Quiet New fund $89M, Oct 2026 VC firm Series B Series A Series C Media And Entertainment Investment Management Follow Auriga Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fauriga-partners) Cheques on record **0%** of best year **0** **cheques in 12 months**, 146 on record Since the last cheque **4127** days **00** hrs **00** min **00** sec Median round **$7.6M** Rounds led **0 of 146** Sole investor **49 rounds** Exits **7 from the portfolio** Mostly in **France, 69%** Pitch Auriga Partners ## Auriga Partners highlights - 01 146 rounds on record - 02 Mostly Series B and Series A: 55% of its rounds - 03 Sole investor in 49 rounds, median $3.6M - 04 7 exits from the portfolio ## What they do > Auriga Partners, une société de gestion de capital-risque pionnière en France depuis 1998 From their own website - **Type:** VC firm - **Cheque size:** Not stated - **Sectors:** Media And Entertainment Investment Management - **Based in:** Paris, France - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **146 appearances** - **2015** 2 rounds - **Jul** **[aveni](https://millionrounds.com/company/aveni)** Venture · FR **$14M** With 4 others - **Jan** **[CoLucid Pharmaceuticals](https://millionrounds.com/company/colucid-pharmaceuticals)** Series C · US **$37M** With 7 others - **2014** 13 rounds - **Dec** **[Nexthink](https://millionrounds.com/company/nexthink)** Series D · CH **$15M** With 3 others - **Dec** **[Pherecydes Pharma](https://millionrounds.com/company/pherecydes-pharma)** Series A · FR **$2.4M** Sole investor - **Nov** **[Theranexus](https://millionrounds.com/company/theranexus)** Seed · PT **$4.5M** With 1 other - **Jul** **[Amoeba](https://millionrounds.com/company/amoeba)** Series A · FR **$889K** Sole investor - **Jun** **[Nexthink](https://millionrounds.com/company/nexthink)** Venture · CH **$7.0M** Sole investor - **Jun** **[Wallix](https://millionrounds.com/company/wallix)** Venture · FR **$1.5M** Sole investor - **May** **[Fab'entech](https://millionrounds.com/company/fab-entech)** Series A · FR **$4.1M** Sole investor - **May** **[Convertigo](https://millionrounds.com/company/convertigo)** Venture · FR **$1.5M** Sole investor - **Apr** **[eXo](https://millionrounds.com/company/exo)** Venture · US **$1.2M** Sole investor - **Apr** **[TxCell](https://millionrounds.com/company/txcell)** Venture · FR **$21M** Sole investor - **Apr** **[SuperSonic Imagine](https://millionrounds.com/company/supersonic-imagine)** Growth · FR **$21M** Sole investor - **Apr** **[aveni](https://millionrounds.com/company/aveni)** Series F · FR **$1.5M** Sole investor - **Mar** **[Stantum](https://millionrounds.com/company/stantum)** Venture · FR **$626K** Sole investor - **2013** 12 rounds - **Dec** **[Median Technologies](https://millionrounds.com/company/median-technologies)** Series F · FR **$680K** Sole investor - **Nov** **[Implanet](https://millionrounds.com/company/implanet)** Series E · FR **$25M** Sole investor - **Oct** **[Genocea Biosciences](https://millionrounds.com/company/genocea-biosciences)** Series E · US · sec.gov **$400K** Sole investor - **Jul** **[Firalis](https://millionrounds.com/company/firalis)** Series B · FR **$1.9M** With 1 other - **Jun** **[Miliboo](https://millionrounds.com/company/miliboo)** Series B · FR **$5.2M** With 2 others - **May** **[BonitaSoft](https://millionrounds.com/company/bonitasoft)** Series C · FR · techcrunch.com **$13M** With 4 others - **May** **[aveni](https://millionrounds.com/company/aveni)** Series E · FR **$4.5M** Sole investor - **Apr** **[SuperSonic Imagine](https://millionrounds.com/company/supersonic-imagine)** Growth · FR · pevc.dowjones.com **$36M** With 8 others - **Apr** **[Ekinops](https://millionrounds.com/company/ekinops)** Series E · FR **$8.6M** Sole investor - **Apr** **[ERYtech Pharma](https://millionrounds.com/company/erytech-pharma)** Series D · FR **$19M** Sole investor - **Mar** **[Population Genetics Technologies](https://millionrounds.com/company/population-genetics-technologies)** Series G · GB **$471K** Sole investor - **Feb** **[Codenvy](https://millionrounds.com/company/codenvy)** Series A · US · techcrunch.com **$9.0M** With 1 other - **2012** 10 rounds - **Nov** **[TxCell](https://millionrounds.com/company/txcell)** Series C · FR · finsmes.com **$16M** With 2 others - **Oct** **[Genocea Biosciences](https://millionrounds.com/company/genocea-biosciences)** Series C · US · masshightech.com **$30M** With 9 others - **Sept** **[Population Genetics Technologies](https://millionrounds.com/company/population-genetics-technologies)** Series F · GB **$1.6M** Sole investor - **Jul** **[DOMAIN Therapeutics](https://millionrounds.com/company/domain-therapeutics)** Venture · FR · finsmes.com **$2.5M** With 3 others - **Jun** **[Wallix](https://millionrounds.com/company/wallix)** Series E · FR **$2.5M** With 2 others - **Apr** **[Eptica](https://millionrounds.com/company/eptica)** Series C · FR **$9.2M** With 1 other - **Mar** **[Nexthink](https://millionrounds.com/company/nexthink)** Series C · CH · finsmes.com **$5.5M** With 1 other - **Jan** **[Amplitude](https://millionrounds.com/company/amplitude)** Series B · FR **$39M** With 3 others - **Jan** **[Neolane](https://millionrounds.com/company/neolane)** Venture · FR · neolane.com **$27M** With 2 others - **Jan** **[IDbyME](https://millionrounds.com/company/idbyme)** Series B **$4.5M** With 2 others - **2011** 11 rounds - **Nov** **[Cytoo](https://millionrounds.com/company/cytoo)** Series C · FR · cytoo.com **$10M** With 2 others - **Nov** **[Wallix](https://millionrounds.com/company/wallix)** Series D · FR **$2.7M** Sole investor - **Oct** **[Population Genetics Technologies](https://millionrounds.com/company/population-genetics-technologies)** Series B · GB · fis.dowjones.com **$5.7M** With 1 other An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **6** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. Who backs their funds ## 2 LPs on record in Auriga Partners's funds - **Funds:** 1 The institutions that put money into its funds, which the firm then invests in companies. Source: fund news. - [**Bpifrance** 1 fund](https://millionrounds.com/fund/bpifrance) Fund Vintage Committed Auriga Partners Auriga Cyber Ventures II - - - [**European Investment Fund** 1 fund](https://millionrounds.com/fund/european-investment-fund-eif) Fund Vintage Committed Auriga Partners Auriga Cyber Ventures II - - ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[Codenvy](https://millionrounds.com/company/codenvy)** Bought by Redhat **Undisclosed** May 2017 **[Neolane](https://millionrounds.com/company/neolane)** Bought by [Adobe Systems](https://millionrounds.com/fund/adobe-systems) **$600M** Jun 2013 **[Streamcore System](https://millionrounds.com/company/streamcore-system)** Bought by ORSYP **Undisclosed** Nov 2012 **[Emulation and Verification Engineering](https://millionrounds.com/company/emulation-and-verification-engineering)** Bought by [Synopsys](https://millionrounds.com/fund/synopsys) **Undisclosed** Oct 2012 **[Open-Plug](https://millionrounds.com/company/open-plug)** Bought by [Alcatel-Lucent](https://millionrounds.com/fund/alcatel-lucent) **Undisclosed** Sept 2010 **[Biolipox](https://millionrounds.com/company/biolipox)** Bought by Orexo **Undisclosed** Nov 2007 **[Spine Next](https://millionrounds.com/company/spine-next)** Bought by [Abbott Labs](https://millionrounds.com/fund/abbott-labs) **Undisclosed** Oct 2004 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$89M** raised in Oct 2026 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series B Series A Series C Median round joined **$7.6M** the round, not its cheque Alone, median **$3.6M** Led 0 of 146 rounds **0%** - **Sole investor:** 49 rounds - **Last cheque:** Jul 2015 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series B *44* - Series A *32* - Series C *26* - Venture *17* - Series D *12* - Series E *7* Cheques by year Led Joined 1999 2015 Often in the room with - [Groupe Siparex](https://millionrounds.com/fund/groupe-siparex) 13 - [Edmond de Rothschild Venture Capital](https://millionrounds.com/fund/edmond-de-rothschild-venture-capital) 12 - [Omnes](https://millionrounds.com/fund/omnes-capital) 11 - [Ventech](https://millionrounds.com/fund/ventech) 11 - [Innovation Capital](https://millionrounds.com/fund/innovation-capital) 10 - [Idinvest Partners](https://millionrounds.com/fund/idinvest-partners) 9 **Pitching Auriga Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Auriga Partners. A count of rooms they were both in, not a relationship either has claimed. [**Groupe Siparex** VC firm **13** rounds together](https://millionrounds.com/fund/groupe-siparex)[**Edmond de Rothschild Venture Capital** Growth equity **12** rounds together](https://millionrounds.com/fund/edmond-de-rothschild-venture-capital)[**Omnes** VC firm **11** rounds together](https://millionrounds.com/fund/omnes-capital)[**Ventech** VC firm **11** rounds together](https://millionrounds.com/fund/ventech)[**Innovation Capital** Accelerator **10** rounds together](https://millionrounds.com/fund/innovation-capital)[**Idinvest Partners** Private equity **9** rounds together](https://millionrounds.com/fund/idinvest-partners)[**Bpifrance** Government **8** rounds together](https://millionrounds.com/fund/bpifrance)[**Seventure Partners** VC firm **8** rounds together](https://millionrounds.com/fund/seventure-partners)[**123Venture** VC firm **7** rounds together](https://millionrounds.com/fund/123venture)[**Sofinnova Partners** VC firm **7** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**XAnge** VC firm **7** rounds together](https://millionrounds.com/fund/xange)[**Ardian** Private equity **6** rounds together](https://millionrounds.com/fund/ardian) ## Quick answers about Auriga Partners ### What does Auriga Partners invest in? Auriga Partners invests most often at Series B and Series A (55% of the rounds on record), in sectors such as Media And Entertainment and Investment Management. ### How active is Auriga Partners? 146 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2015. ### How big are Auriga Partners's cheques? The median round it joins is $7.6M. ### Does Auriga Partners lead rounds? Rarely, if at all: none of its 146 investments on record names it as the lead. ### Where does Auriga Partners invest? Most of the companies it backs are in France (69%), the United States (13%) and Switzerland (8%). ### Is Auriga Partners investing now? No investments in the last 12 months; the latest was in Jul 2015. ### Who does Auriga Partners invest alongside? Most often Groupe Siparex (13 rounds together), Edmond de Rothschild Venture Capital (12 rounds together) and Omnes (11 rounds together). ### What kind of investor is Auriga Partners? Auriga Partners is a VC firm based in Paris, France. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=auriga-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=auriga-partners)